SUMMARY In isolated rat spleen perfused with Tyrode's solution, prostaglandin (PG) Ei and E2, 0.2-2.5 ng/ml, reduced the vasoconstrictor responses to sympathetic nerve stimulation by 38-89% and 35-73% and to injected norepinephrine by 18-53% and 18-34%, respectively. In contrast, PGF 2o and thromboxane B2 (TXB2) produced vasoconstriction and potentiated the vascular responses to both adrenergic stimuli, whereas PGD2 had variable effects. Stimulation of adrenergic nerves or an injection of norepinephrine enhanced the efflux of a PGE-like substance from the rat spleen. Administration of a PG synthetase inhibitor, indomethacin, 100 ng/ml, abolished the efflux of PGE evoked by adrenergic stimuli and potentiated the vasoconstrictor responses to nerve stimulation and to injected norepinephrine. The facilitatory effect of indomethacin on the vasoconstrictor responses to both adrenergic stimuli was abolished by the infusion of PGE 2 . A PG precursor, arachidonic acid, inhibited the vasoconstrictor responses to nerve stimulation and to injected norepinephrine. Because the inhibitory effect of arachidonic acid was abolished by the administration of indomethacin, it appears to be mediated, at least in part, through the conversion of the acid to a PG(s). These observations and the effect of exogenous PGE compounds suggest that PGs of the E series participate in the modulation of the vascular responses of the rat spleen to adrenergic stimuli. However, the modulatory effect of PGE compounds varies in different vascular beds of rat, viz, facilitatory in renal and mesenteric vasculature and inhibitory in the splenic vasculature. This study also indicates that other products of arachidonic acid metabolism, including PGF2 O and TxB2, also may contribute to the modulation of vascular responses to adrenergic stimuli and affect the actions of PGE2 at the adrenergic neuroeffector junction in the rat spleen.
STIMULATION of sympathetic nerves, as well as administration of norepinephrine, increases the output of prostaglandins (PGs) and particularly of a PGE-like substance from various tissues of different species. 1 
"
4 Since (1) the administration of PGE compounds diminishes the output of norepinephrine evoked by sympathetic nerve stimulation 1 ' 5 " 7 and reduces the response of several tissues to adrenergic stimuli, I ' 5>6 -8~" and (2) blockade of PG synthesis facilitates norepinephrine release 12 ' 13 and augments the vascular responses to adrenergic stimuli, 7 ' 10~12 it was proposed that PGE compounds function as inhibitory modulators of the vasoconstrictor responses to adrenergic stimuli. However, the demonstration that PGE compounds, which inhibit the vasoconstrictor responses of the rabbit renal and mesenteric vasculature, produce an opposite effect in the rat, viz, potentiate the vascular responses to adrenergic stimuli, suggested that the modulatory effect of PGE compounds on the adrenergic neuroeffector junction is species dependent. 10 ' " The present study was undertaken to examine the effects of PGEi, PGE 2 , and some other products of arachidonic acid metabolism, PGF^, PGD 2 , and thromboxane (Tx) B2 on the vasoconstrictor responses of the isolated rat splenic vasculature, perfused with Tyrode's solution, to periarterial nerve stimulation and to injected norepinephrine. To determine the contribution of endogenous PGs in the modulation of vascular reactivity to adrenergic stimuli, the output of PGs evoked by sympathetic nerve stimulation and injected norepinephrine and the consequence of blockade of PG synthesis with indomethacin 14 on the vascular responses to adrenergic stimuli were examined. The results of this study indicate an important difference in the effect of PGs on vascular tone and vascular reactivity to adrenergic stimuli in various organs of the rat.
its nerve plexus and the portal vein were dissected free from the surrounding tissue. A stainless steel cannula was advanced through the coeliac artery and the tip of the cannula positioned close to the splenic artery. The spleen was then flushed with heparinized saline (100 U/ml). The rat was killed by an incision in the heart. The portal vein was cut, and the spleen was immediately isolated by dissecting the surrounding tissue and was transferred to a thermostatically controlled Plexiglas box, where it was covered with cotton gauze moistened with Tyrode's solution. The spleen was perfused at a constant rate of 5 ml/min, with a Harvard peristaltic pump (model 1203). The millimolar composition of the Tyrode's solution was: NaCl, 137; KC1, 2.7; CaCl 2 , 1.8; MgCl 2 , 1.1; NaHCO 3 , 12; NaH 2 PO 4 , 0.42; and D-glucose, 5.6. The fluid perfusing the spleen flowed from the cut end of the portal vein. The perfusion fluid was maintained at a temperature of 37°C and aerated with a mixture of 95% O 2 -5% CO 2 . Changes in perfusion pressure were measured with a mercury manometer and recorded on a kymograph equipped with an isotonic frontal writing lever. Before cannulation of the coeliac artery, the pressure in the cannula was 15 mm Hg at a flow rate of 5 ml/min. During perfusion of the spleen, the pressure in the cannula increased by an average of 75 mm Hg (range, 60-85 mm Hg).
A bipolar platinum electrode was placed on the periarterial nerve plexus about 2 mm distal to the cannula. The nerves were stimulated at 0.3 Hz, using supramaximal biphasic rectangular pulses, 1 msec in duration, for 22 seconds at 4-minute intervals with a Grass stimulator (S 44 ).
At 4-minute intervals, either the perarterial nerves were stimulated or norepinephrine was infused directly into the arterial cannula in a volume of 0.05 ml for 10-20 seconds with an infusion pump (Braun-Melsungen), using an automatic timer. The dose of norepinephrine was varied (range, 50-70 ng) to produce control vasoconstrictor responses, the magnitude of which was not significantly different (P > 0.5) from the control responses produced by stimulation of periarterial nerves for 22 seconds. All other drugs were infused into the spleen randomly. Changes in the vasoconstrictor responses to nerve stimulation and to injected norepinephrine produced by various agents were calculated, without taking into account alterations in the basal perfusion pressure, by comparing the mean height of the vasoconstrictor responses during the infusion of an agent for 16-24 minutes with the mean height of control responses in the absence of the drug.
Determination of Prostaglandins
Release of prostaglandin-like substance from the rat spleen perfused with Tyrode's solution in response to nerve stimulation (0.3 Hz, 1 msec duration, supramaximal voltage) or to norepinephrine (30-50 ng), injected directly into the cannula leading to the coeliac artery, was detected in the perfusate from rat spleen by continuously superfusing a series of assay tissues, according to the procedure of Vane. 15 ' 16 Assay tissues included the rat stomach strip, chick rectum and rat colon. The initial resting load on the tissues was 2-3 g, and their contractions were measured by Harvard smooth muscle tiansducers and recorded on a physiograph (Rikadenki). The tissues were made insensitive to acetylcholine, histamine, 5-hydroxytryptamine, and catecholamines by continuously infusing a mixture of antagonists 2 into the superfusing fluid to give the following final concentration of the active bases: hyoscine, 10" 7 g/ml; methysergide, 2 X 10~7 g/ml; phenoxybenzamine, 10" 7 g/ml; pyrilamine, 10" 7 g/ml; and propranolol, 2 X 10~6 g/ml. Indomethacin, an inhibitor of PG synthesis, 14 also was included in the fluid superfusing the assay organs distal to spleen to give a final concentration of 5 jug/ml. Prostaglandins E2, F 2o , D 2 , and TxB 2 standards were administered directly into the fluid superfusing the assay organs.
The nature of PG-like material released from rat spleen in response to adrenergic stimuli was further investigated by collecting the splenic perfusate for 10-minute periods before and during periarterial nerve stimulation (0.3 Hz, 1 msec) in the absence and presence of indomethacin. The splenic effluent was adjusted to pH 3 with formic acid, and the acidic lipids were separated from the neutral lipids by extraction with ethyl acetate followed by extraction with potassium phosphate buffer and, finally, with chloroform. The acidic lipids so obtained were separated by thin layer chromatography on 0.5-mm thick silica gel plates (Brinkman Instruments) using the solvent system chloroform-methanol-acetic acid (18:2:1, by volume). Marker plates prepared by spotting 10 fig of authentic PGE 2 , PGF 2a , PGD 2 , and TxB 2 were run concurrently with preparative plates. Spots of authentic PGs on the marker plates were localized by spraying with 10% phosphomolybdic acid in ethanol, followed by heating at 100°C for 15 minutes. The zones on the preparative plates corresponding to the position of authentic PGE2, PGF 2o , PGD2, and TxB 2 on the marker plates were scraped, as were the areas between them, and the remainder of each plate divided into five 2-cm zones and scraped. Each zone was eluted separately with chloroform-methanol (4:1 vol/vol). Eluates were dried in a nitrogen atmosphere, reconstituted in 1 ml of saline, and 0.1-ml samples of this solution were tested for PG-like activity, using PGE 2 , PGF 2a , PGD 2 , and TxB 2 as reference standards, respectively, on rat stomach strip and rat colon. The isolated organs were suspended in glass chambers and superfused in series with Krebs solution (3 ml/min, 37°C), and thencontractions were measured with Harvard muscle transducers and recorded on a physiograph.
Drugs
The concentration of norepinephrine bitartrate (Winthrop) is expressed as the free base. Prostaglandins Ei, E 2 , D 2 , and F20 tromethamine and thromboxane B 2 were dissolved in ethanol (1 mg/ml); arachidonic acid (10 mg) was dissolved in 1 ml of hexane and mixed with 2 ml of sodium carbonate (0.1%) and then exposed to nitrogen to evaporate the hexane. Further dilutions of PGs and arachidonic acid solutions were made with Tyrode's solution. These diluted solutions were then added to the perfusion fluid to obtain the final concentration. Control Tyrode's solution perfusing the splenic blood vessels contained the same amount of ethanol (0.2-2.5 nl/ml) or sodium carbonate (20 ng/ml) as did the drug-containing Tyrode's solution. The amount of ethanol or sodium carbonate present in the control Tyrode's solution did not affect the vascular tone or the vasconstrictor responses to nerve stimulation or injected norepinephrine. 6-Hydroxydopamine hydrobromide, which depletes sympathetic nerves of their catecholamines, 17 was dissolved in 1 ml of saline and immediately injected intraperitoneally (100 mg/kg) twice at 24-hour intervals. All other drugs were dissolved in Tyrode's solution and added to the perfusion fluid to obtain the final concentration, whereas norepinephrine was injected directly into the arterial cannula.
Statistical Analysis
Paired and unpaired t-tests were performed according to the methods described by Steel and Torrie. 18 
Results

Effect of Periarterial Nerve Stimulation and Injected Norepinephrine on Perfusion Pressure in Isolated Perfused Rat Splenic Vasculature and Modification by Ganglionic and Adrenergic Neuron Blocking Agents and by Chemical Sympathectomy
Stimulation of periarterial nerves or injections of norepinephrine directly into the arterial cannula constricted splenic vessels and increased the perfusion pressure. The rise in perfusion pressure was related to the frequency of nerve stimulation, as well as the amount of norepinephrine injected into the arterial cannula ( Fig. 1 ). Repeated stimulation of periarterial nerves (0.1-0.5 Hz) or injections of norepinephrine (30-80 ng) at 4-minute intervals during a 3-hour period did not cause diminution of the vasoconstrictor responses. The vasoconstrictor responses of rat spleen to both adrenergic stimuli remained unaltered during the infusion of a ganglionic blocking agent, hexamethonium, 19 10-100 jug/ml, (five preparations), whereas administration of guanethidine, 0.5 fig/ml (six preparations), which blocks sympathetic transmission, inhibited the vasoconstrictor responses to nerve stimulation but increased the responses to injected norepinephine by 14 ± 3% (± SEM); the change was statistically insignificant. Moreover, in four preparations isolated from rats pretreated with 6-hydroxydopamine, stimulation of periarterial nerves did not alter the perfusion pressure, whereas injections of norepinephrine (50-60 ng) produced a 30 ± 4% greater degree of constriction of splenic vessels than was obtained from untreated rats. Therefore, it produced a fall in basal perfusion pressure and decreased the vasoconstrictor responses to both adrenergic stimuli ( Fig. 2 and Table 1 ).
FIGURE 1 Effect of periarterial nerve stimulation (NS) (upper panel) and injections of norepinephrine (NE) (lower panel) in
Prostaglandin Fa, PGF 2o , 0.2-1 ng/ml, consistently increased the basal perfusion pressure and potentiated the vasoconstrictor responses of splenic vasculature to both adrenergic stimuli ( Fig. 3 and Table 1 ). In five preparations, infusion of PGF 2o , 0.5-1 ng/ml, abolished the fall in basal perfusion pressure and the inhibitory effect on the vasoconstrictor responses to nerve stimulation and to injected norepinephrine produced by PGE 2 , 2.5 ng/ml (Fig. 4) . preparations by 9-40% and increased in four preparations by 12-50%.
Prostaglandin D2
Thromboxane B 2
Thromboxane B 2 (TxB 2 ) is derived by the breakdown of a biologically active and an unstable product of arachidonic acid metabolism, TxA 2 , in platelets and some other tissues including spleen. 20 TxB 2 has been synthesized by Nelson and Jackson 21 and shown to be similar to the naturally occurring compound. Infusion of TxB 2) 0.2-2.5 ng/ml, affected neither the basal perfusion pressure nor the vasoconstrictor responses to nerve stimulation or injected norepinephrine. TxB2, in concentrations of 5-100 ng/ml, invariably increased the basal perfusion pressure (3-6 mm Hg) and potentiated the vasoconstrictor responses to nerve stimulation and to injected norepinephrine ( Table 1) . Potentiation of the vasoconstrictor responses to both adrenergic stimuli produced by TxB 2 , 5 ng/ml, was not significant, whereas that caused by higher concentrations was statistically significant (Table 1) . In four preparations, the infusions of TxB 2 , 100-150 ng/ml, abolished the fall in basal perfusion pressure and the inhibition of the vasoconstrictor responses to nerve stimulation and to injected norepinephrine produced by PGE 2( 2.5 ng/ml.
In three rat spleens, the effect of PGE,, PGE 2 , PGF 2o , and TxB 2 was examined on the vasoconstrictor responses produced by either stimulation of nerve fibers at 0.1, 0.2, and 0.5 Hz, or by injections of norepinephrine in doses of 30, 40, 60, and 80 ng. Results similar to those observed in experiments in which nerves were stimulated at 0.3 Hz or norepinephrine was injected in doses of 50-70 ng were obtained, viz, PGEi and PGE 2 inhibited, whereas PGF 2o and TxB 2 potentiated the vasoconstrictor responses to both adrenergic stimuli.
Release of Prostaglandins from the Isolated Perfused Rat Spleen in Response to Periarterial Nerve Stimulation and to Injected Norepinephrine
In the rat spleen, stimulation of periarterial nerves for 1 minute (0.3-0.5 Hz) or an injection of norepinephrine (20-50 ng) directly into the arterial cannula raised the perfusion pressure and released a substance having a smooth muscle-stimulating activity like PGE 2 (five preparations). It caused contraction of rat stomach strip and chick rectum but had no effect on rat colon (Fig. 5) . Direct administration of PGE 2 , 1-4 ng, into the fluid superfusing the assay organs caused contraction of rat stomach strip and chick rectum, but had little or no effect on the rat colon, whereas PGF2,, contracted the rat colon but usually had only l/3-l/5th the potency of PGE 2 in contracting rat stomach strip and chick rectum. Prostaglandin D 2 and TxB 2 had l/200th and 1/1000th the musculotropic activity of PGE 2 on the assay organs (not shown in figures). Since the assay organs were constantly exposed to an inhibitor of PG synthesis, release of a PGElike substance could only arise from the perfused rat spleen. In addition, the fluid superfusing the assay organs contained receptor antagnoists of acetylcholine, histamine, serotonin, and catecholamines; therefore, norepinephrine or any of the other substances released in re- sponse to nerve stimulation or exogenously administered norepinephrine could not produce any direct effect on the assay organs. Infusion of indomethacin, 100 ng/ml, into the spleen abolished within 3-4 minutes the output of a PGE-like substance as indicated by the absence of contraction of assay organs, but did not abolish the response to PGs applied directly over the assay organs (Fig. 5) .
Restoration of release of a PGE-like substance from the spleen in response to adrenergic stimuli occurred 1.5-2 hrs after perfusion with indomethacin-free Tyrode's solution. Bioassay of the purified acid lipid extracts of the splenic perfusate obtained from different zones of thin layer silica gel plates showed musculotropic activity in zones corresponding to the locus of PGE2. The activity in eluates of zones corresponding to PGF^, if any, was below the level of sensitivity of bioassay. Efflux of PGE-like substance in the splenic perfusate collected before nerve stimulation and expressed as PGE 2 equivalent was 0.5 ng/min; during nerve stimulation it increased to 1 ng/min. Perfusate collected during nerve stimulation from spleen pretreated with indomethacin, 100 ng/ml, for 15 minutes showed no musculotropic activity in zones corresponding to PGE 2 standard on the plate. Other PGs having a chromatographic mobility similar to that of PGE2 in the solvent system chloroform-methanol-acetic acid (18:2:1), e.g., 6-keto PGFi o , a stable derivative of PGI 2 , could contribute to the musculotropic activity of the eluates from the "PGE" zone of the chromatographic plates. 22 However, this seems to be less likely since 6-keto PGFi possesses l/500th the activity of PGE 2 on the rat stomach strip (unpublished observation). Moreover, like PGE 2 (10-20 ng), the myotropic activity present in the eluates obtained from a zone of the plate corresponding to the migration of authentic PGE 2 disappeared after alkaline treatment with NaOH (pH 12 at 100°C for 5 minutes). This behavior is compatible with PGE compounds rather than 6-keto PGF lo , which is resistant to an alkaline treatment. The rise in perfusion pressure produced by sympathetic nerve stimulation and by injected norepinephrine was increased by low concentrations of indomethacin, 100 ng/ml (Figs. 5 and 6 ). The degree of augmentation of the vasoconstrictor responses to nerve stimulation produced by indomethacin was greater than that to injected norepinephrine (Table 1) . Addition of PGE 2 , 1 ng/ml, into the perfusion fluid abolished the facilitory effect of indomethacin and reduced the vasoconstrictor responses to adrenergic stimuli. A potentiating effect of indomethacin, 100 ng/ml, on the vasoconstrictor responses to adrenergic stimuli was also observed in four preparations perfused with Tyrode's solution containing cocaine, 1 fig/ml, an inhibitor of neuronal uptake of norepinephrine. In the rat spleen, indomethacin, 1 /ig/ml, also abolished the output of a PGE-like substance evoked by adrenergic stimuli and 
FIGURE 4 Effect of PGF^ on the inhibitory effect of PGE 2 on the vascular tone and on the vasoconstrictor responses of the rat splenic vasculature to nerve stimulation (NS) (0.3 Hz) and to injected norepinephrine (NE) (50 ng).
reduced the vasoconstrictor responses to nerve stimulation and to injected norepinephrine without altering the basal perfusion pressure. Higher concentrations of indomethacin, 5 /ig/ml, produced a fall in basal perfusion pressure and decreased the vasoconstrictor responses to both adrenergic stimuli (Fig. 6 and Table 1 ).
Effect of Arachidonic Acid on the Vasoconstrictor Responses of Perfused Rat Spleen to Periarterial Nerve Stimulation and Injected Norepinephrine
In six splenic preparations, infusion of a precursor of PGs, arachidonic acid, invariably reduced the vasoconstrictor responses to nerve stimulation to a greater degree than responses to injected norepinephrine (Table 1 and Fig. 7 ). Simultaneous infusion of indomethacin, 100 ng/ml, abolished the inhibitory effect of arachidonic acid on the vasoconstrictor responses to both adrenergic stimuli. However, addition of PGE2, 1 ng/ml, to the perfusion fluid restored the inhibitory effect of arachidonic acid on the vasoconstrictor responses to adrenergic stimuli (Fig.  7) .
Discussion
The present findings indicate that PGs of the E series affect vascular responses of the rat spleen to sympathetic nerve stimulation and to injected norepinephrine in a direction opposite to that reported for the renal 10 and mesenteric" vasculature of this species. Thus, PGEi and PGE 2 , which potentiated the vascular responses of the rat renal 10 and mesenteric 1 ' vasculature to adrenergic stimuli, produced vasodilation and reduced the vasoconstrictor responses of the splenic vasculature to sympa- 
FIGURE 5 Efflux of prostaglandins (PGs) from the isolated rat spleen perfused with Tyrode's solution in response to periarterial nerve stimulation (NS) and to injected norepinephrine (NE). Prostaglandins E 2 and F 2a were given as bolus injections directly (DIR) into the fluid superfusing the rat stomach strip (RSS), chick rectum (CR), and rat colon (RC
FIGURE 6 Effect of indomethacin (Ind) on the vasoconstrictor responses of the isolated perfused rat spleen to periarterial nerve stimulation (NS) (0.3 Hz) and to injected norepinephrine (NE) (65 ng). Each tracing represents vasoconstrictor responses of a different rat spleen.
FIGURE 7 Effect of arachidonic acid (AA) on the vasoconstrictor responses of the isolated perfused rat spleen to periarterial nerve stimulation (NS) (0.3 Hz) and to injected norepinephrine (NE) (55 ng) and its modification by indomethacin (Ind) and prostaglandin Ei (PGE 2 ). Each tracing represents vasoconstrictor responses of a different rat spleen.
centrations of indomethacin in the rat spleen is most likely due to a direct effect of this agent on the vascular smooth muscle, since termination of the infusion of indomethacin resulted in restoration of vascular tone and vasoconstrictor responses to control levels despite persistent inhibition of PG synthesis. The role of endogenous PGs as modulators of the vasoconstrictor responses to adrenergic stimuli also is supported by the demonstration that arachidonic acid, a precursor of PGs, inhibited the vasoconstrictor responses to nerve stimulation and to injected norepinephrine.
Since the inhibitory effect of arachidonic acid was abolished during the infusion of the PG synthesis inhibitor, indomethacin, it appears that a product or products of arachidonic acid metabolism participate in its action on the vascular responses to adrenergic stimuli. These observations and the present demonstration that PGEi and PGE 2 inhibited the vasoconstrictor responses to adrenergic stimuli are consistent with the hypothesis 10 
"
12 that PGE compounds participate in the modulation of vascular responses to adrenergic stimuli. These data, however, do not permit the exclusion of the contribution of other MODULATION OF VASCULAR REACTIVITY/Ma/^233 products of arachidonic acid metabolism in the rat spleen, i.e., cyclic endoperoxides PGG 2 and PGH 2 , TxA 2 , PGI 2 , PGF2,,, and PGD 2 , 2Oi 2? in the modulation of vascular responses to adrenergic stimuli. This is so because indomethacin inhibits primarily the conversion of arachidonic acid to cyclic endoperoxides PGG 2 and PGH 2 , which give rise to TxA 2 and various prostaglandins. Although the major product of arachidonic acid metabolism in blood vessels appears to be PGI^2 8 rat spleen has been shown to synthesize larger amounts of TxB 2 , a stable derivative of TxA 2 , than PGI 2 , PGE 2 , PGF 2a , or PGD,. 20 These observations and the present demonstration that TxB 2 caused vasoconstriction and potentiated the vascular responses to nerve stimulation and to injected norepinephrine suggest that TxB 2 and probably its biologically active precursor TxA 2 also could participate in the modulation of vascular responses to adrenergic stimuli. Moreover, in view of the presence in several tissues of an enzyme, PGE 2 -9-keto-reductase, 29 ' 30 which converts PGE to PGF compounds, and the demonstration that PGF 2o , like TxB 2 , caused vasoconstriction and augmented the vascular responses to adrenergic stimuli, it is possible that PGF 2o and TxB 2 -depending upon the species and vascular bed-could either oppose (rat, dog, and cat spleen, rabbit renal and mesenteric vasculature) or contribute to (rat renal and mesenteric vasculature) the modulatory effect of PGE2 on vascular reactivity to adrenergic stimuli. Supporting this view was the demonstration that the vasodilator and the inhibitory effects of PGE 2 on the vasoconstrictor responses of the rat spleen to nerve stimulation and to injected norepinephrine were abolished by the administration of either PGF 2a or TxB 2 .
The present study indicates that PGs may participate in the modulation of the vasoconstrictor responses of the isolated rat spleen to sympathetic nerve stimulation and to injected norepinephrine. However, the direction of modulation may vary with the type of PG and vascular bed within the same species. Thus, PGF 2o and TxB 2 increased vascular tone and potentiated the vasoconstrictor responses to adrenergic stimuli, whereas PGEi and PGE 2 , which potentiated the vascular responses to adrenergic stimuli in the rat renal and mesenteric vessels, produced an inhibitory effect in the spleen, viz, reduced the vasoconstrictor responses to adrenergic stimuli. The opposite direction of modulation by PGE compounds and PGF 2a and TxB 2 in the rat splenic vasculature and of PGE compounds in the renal and mesenteric and splenic vessels of this species, which could be attributed to differences in PG receptors or the events resulting from PG receptor interaction, remains to be determined.
